IAGX (Imagenetix) Notes Receivable: $0.00 Mil (As of Jun. 2015)


What is Imagenetix Notes Receivable?

Imagenetix IAGX -99.00% Notes Receivable is $0.00 Mil as of Jun. 2015.

Imagenetix's Notes Receivable for the quarter that ended in Jun. 2015 was $0.00 Mil.

Imagenetix Notes Receivable Historical Data

* Premium members only.

The historical data trend for Imagenetix's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imagenetix Notes Receivable Chart

Imagenetix Annual Data
Trend Mar04 Mar05 Mar06 Mar07 Mar08 Mar09 Mar10 Mar11 Mar13 Mar15
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Imagenetix Quarterly Data
Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Dec12 Mar13 Jun13 Jun14 Sep14 Dec14 Mar15 Jun15
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Imagenetix Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Imagenetix (IAGX) has a Notes Receivable of $0.00 Mil as of Jun. 2015. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Imagenetix and its competitors.
Is Imagenetix's Notes Receivable too high?
Imagenetix's current Notes Receivable is $0.00 Mil.
How does Imagenetix's Notes Receivable compare to NUVPF and ADMD?
Imagenetix's Notes Receivable of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Imagenetix and its competitors. Imagenetix's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imagenetix stock overvalued right now?
Imagenetix (IAGX) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Imagenetix (IAGX), the current Notes Receivable is $0.00 Mil as of Jun. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imagenetix Business Description

Address 10845 Rancho Bernardo Road, Suite 105, San Diego, CA, USA, 92127
Imagenetix Inc is engaged in developing, formulating licensing and selling over-the-counter, natural-based nutritional supplements. Its products include Celadrin, a product formulation for joint health; and Periodyne a periodontal product. These products are offered through multiple channels of distribution, including direct marketing companies, also known as network marketing or multi-level marketing companies and chain store retailers. Geographically all the business activities are functioned primarily through the United States.